TherapeuticsMD Inc (TXMD)

ENERGY: OIL & GAS PRODUCTION
SIC: PHARMACEUTICAL PREPARATIONS

951 YAMATO ROAD, SUITE 220 BOCA RATON, FL 33431

TherapeuticsMD, Inc. is an innovative, leading healthcare company, focused on developing and commercializing novel products exclusively for women. Our products are designed to address the unique changes and challenges women experience through the various stages of their lives with a therapeutic focus in family planning, reproductive health, and menopause management. The Company is committed to advancing the health of women and championing awareness of their healthcare issues.

Data as of 2021-07-25 16:51:24 -0400
Market Cap408.918 Million Shares Outstanding393.19 Million Avg 30-day Volume5.837 Million
P/E Ratio-2.46249 Dividend Yield0.0 EPS-0.564
Price/Sales5.42 Debt to Equity-25.25 EBITDA-133.116 Million
Price to Book Value-41.48 Forward PE-2.52 Enterprise Value439.543 Million
Total Cash137.617 Million Current Debt61.284 Million Gross Profit54.541 Million
BETA1.14721 52-week High/Low2.75 / 0.93 Next Earnings Date2021-08-05 Price to Cash FLow (P/CF) -11.7196
Data provided by IEX Cloud
View SEC Filings from TXMD instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 162 161 0.62% 37 (2.17%) 34 (1.97%) 8.82%
13F shares: 174.051 Million 161.099 Million 8.04% 38.444 Million 42.005 Million -8.48%
% Ownership 44.8788 53.7416 -16.49% 9.9127 14.0125 -29.26%
New Positions: 28 31 -9.68% 12 8 50.0%
Increased Positions 61 45 35.56% 6 12 -50.0%
Closed Positions 25 12 108.33% 9 5 80.0%
Reduced Positions 28 39 -28.21% 10 7 42.86%
Total Calls 1.908 Million 869.569 Thousand 119.37% 297.2 Thousand 338.9 Thousand -12.3%
Total Puts 1.15 Million 960.691 Thousand 19.72% 184.9 Thousand 112 Thousand 65.09%
PUT/CALL Ratio 0.6 1.1 -45.45% 0.62 0.33 87.88%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding TXMD (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding TXMD BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

COLLINS COOPER C.

  • Director
99,174 2021-07-01 1

RUSSELL ANGUS C.

  • Director
99,174 2021-07-01 1

CARROLL J MARTIN

  • Director
99,174 2021-07-01 1

MUSING JULES A.

  • Director
99,174 2021-07-01 1

THOMPSON TOMMY G

  • Director
148,760 2021-07-01 2

FINIZIO ROBERT G CEO

  • Officer
  • Director
2,240,000 2021-07-01 4

DONEGAN MICHAEL C CAO AND VP FINANCE

  • Officer
240,000 2021-07-01 3

BISARO PAUL

  • Director
99,174 2021-07-01 1

NAUGHTON GAIL K

  • Director
99,174 2021-07-01 1

LING KAREN

  • Director
99,174 2021-07-01 1

DARECCA JAMES CFO

  • Officer
520,000 2021-07-01 1

BORKOWSKI EDWARD EVP, OPERATIONS

  • Officer
560,000 2021-07-01 3

WALKER MARLAN D GENERAL COUNSEL

  • Officer
520,000 2021-07-01 3

MILLIGAN JOHN C.K. IV SECRETARY/CEO OF SUBSIDIARY

  • Officer
5,335,076 2021-05-10 3

KRASSAN MITCHELL CHIEF STRATEGY OFFICER

  • Officer
0 2020-03-30 0

CARTWRIGHT DANIEL A CHIEF FINANCIAL OFFICER

  • Officer
0 2020-03-30 0

BERNICK BRIAN

  • Director
6,658,371 2019-10-25 0

BARLOW JANE F

  • Director
3,144 2019-08-12 0

SEGAL NICHOLAS

  • Director
0 2019-06-20 0

LAPENTA ROBERT V JR

  • Director
0 2019-06-20 0

HOWES JEFFREY D

  • NONE
No longer subject to file 2011-10-04 0

CAMBRIDGE ROBERT

  • NONE
No longer subject to file 2011-02-15 0

MASTROPIETRO DONALD R

  • NONE
No longer subject to file 2010-12-17 0

TJON ROBIN NATALIE

  • NONE
No longer subject to file 2010-12-17 0

SARUBBI KIMBERLY

  • NONE
No longer subject to file 2010-12-17 0

RICHARDSON CHARLES V

  • Director
0 2009-08-14 0

KELLEY SKY B PRESIDENT, CEO

  • Officer
  • Director
  • 10% Owner
3,423,422 2009-07-27 0

GOLDEN ANDREW E

  • Director
0 2009-07-27 0

MANDEL RICHARD H JR

  • Director
13,100 2008-06-21 0

HAMILTON DAVID S

  • Director
0 2008-06-17 0

WOODHILL GREGORY PRESIDENT, SECRETARY, CFO

  • Officer
  • Director
0 2008-06-17 0

CHESTER MICHAEL

  • Director
0 2008-06-17 0

TERRACE LANE, LLC

  • 10% Owner
646,000 2008-06-17 0

JENSEN JULIAN D

  • Director
0 2008-06-17 0

JENSEN DEVELOPMENT CO FORMER PRESIDENT

  • Officer
  • Director
  • 10% Owner
0 2008-06-17 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

WALKER MARLAN D - Officer GENERAL COUNSEL

2021-07-02 17:48:12 -0400 2021-07-01 A 346,667 a 346,667 direct

LING KAREN - Director

2021-07-02 18:14:59 -0400 2021-07-01 A 99,174 a 99,174 direct

RUSSELL ANGUS C. - Director

2021-07-02 18:07:17 -0400 2021-07-01 A 99,174 a 99,174 direct

COLLINS COOPER C. - Director

2021-07-02 17:59:40 -0400 2021-07-01 A 99,174 a 99,174 direct

THOMPSON TOMMY G - Director

2021-07-02 17:56:47 -0400 2021-07-01 A 148,760 a 148,760 direct

DONEGAN MICHAEL C - Officer CAO AND VP FINANCE

2021-07-02 17:42:35 -0400 2021-07-01 A 80,000 a 80,000 direct

DARECCA JAMES - Officer CFO

2021-07-02 17:45:52 -0400 2021-07-01 A 346,667 a 346,667 direct

CARROLL J MARTIN - Director

2021-07-02 18:11:51 -0400 2021-07-01 A 99,174 a 99,174 direct

NAUGHTON GAIL K - Director

2021-07-02 18:04:56 -0400 2021-07-01 A 99,174 a 99,174 direct

FINIZIO ROBERT G - Director - Officer CEO

2021-07-02 17:54:22 -0400 2021-07-01 A 746,667 a 746,667 direct

BORKOWSKI EDWARD - Officer EVP, OPERATIONS

2021-07-02 17:51:32 -0400 2021-07-01 A 186,667 a 186,667 direct

DONEGAN MICHAEL C - Officer CAO AND VP FINANCE

2021-07-02 17:42:35 -0400 2021-07-01 A 160,000 a 160,000 direct

WALKER MARLAN D - Officer GENERAL COUNSEL

2021-07-02 17:48:12 -0400 2021-07-01 A 173,333 a 173,333 direct

MUSING JULES A. - Director

2021-07-02 18:09:43 -0400 2021-07-01 A 99,174 a 99,174 direct

BISARO PAUL - Director

2021-07-02 18:02:30 -0400 2021-07-01 A 99,174 a 99,174 direct

FINIZIO ROBERT G - Director - Officer CEO

2021-07-02 17:54:22 -0400 2021-07-01 A 1,493,333 a 1,493,333 direct

BORKOWSKI EDWARD - Officer EVP, OPERATIONS

2021-07-02 17:51:32 -0400 2021-07-01 A 373,333 a 373,333 direct

DARECCA JAMES - Officer CFO

2021-07-02 17:45:52 -0400 2021-07-01 A 173,333 a 173,333 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
THERAPEUTICS MD INC TXMD 2021-07-28 17:45:03 UTC -1.1607 1.2407 4800000
THERAPEUTICS MD INC TXMD 2021-07-28 17:15:03 UTC -1.1607 1.2407 4800000
THERAPEUTICS MD INC TXMD 2021-07-28 16:45:03 UTC -1.1607 1.2407 4800000
THERAPEUTICS MD INC TXMD 2021-07-28 16:15:02 UTC -1.1607 1.2407 4800000
THERAPEUTICS MD INC TXMD 2021-07-28 15:45:03 UTC -1.1607 1.2407 4800000
THERAPEUTICS MD INC TXMD 2021-07-28 15:15:03 UTC -1.1607 1.2407 4800000
THERAPEUTICS MD INC TXMD 2021-07-28 14:45:02 UTC -1.1609 1.2409 5100000
THERAPEUTICS MD INC TXMD 2021-07-28 14:15:03 UTC -1.1609 1.2409 5100000
THERAPEUTICS MD INC TXMD 2021-07-28 13:45:02 UTC -1.1609 1.2409 5100000
THERAPEUTICS MD INC TXMD 2021-07-28 13:15:03 UTC -1.1609 1.2409 5000000
THERAPEUTICS MD INC TXMD 2021-07-28 12:45:03 UTC -1.1609 1.2409 4800000
THERAPEUTICS MD INC TXMD 2021-07-27 22:15:03 UTC -1.1609 1.2409 4600000
THERAPEUTICS MD INC TXMD 2021-07-27 21:45:03 UTC -1.1609 1.2409 4600000
THERAPEUTICS MD INC TXMD 2021-07-27 21:15:03 UTC -1.1609 1.2409 4600000
THERAPEUTICS MD INC TXMD 2021-07-27 20:45:03 UTC -1.1624 1.2424 4600000
THERAPEUTICS MD INC TXMD 2021-07-27 20:15:03 UTC -1.1624 1.2424 4700000
THERAPEUTICS MD INC TXMD 2021-07-27 19:45:02 UTC -1.1624 1.2424 4700000
THERAPEUTICS MD INC TXMD 2021-07-27 19:15:02 UTC -1.1624 1.2424 4700000
THERAPEUTICS MD INC TXMD 2021-07-27 18:45:03 UTC -1.1619 1.2419 4800000
THERAPEUTICS MD INC TXMD 2021-07-27 18:15:02 UTC -1.1619 1.2419 5100000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
RUSSELL INVESTMENT FUNDS- U.S. Small Cap Equity Fund TXMD -52747.0 shares, $-70680.98 2021-03-31 N-PORT
RUSSELL INVESTMENT CO- U.S. Small Cap Equity Fund TXMD -460999.0 shares, $-557808.79 2021-04-30 N-PORT

Elevate your investments